ロード中...
Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer
BACKGROUND: A large number of patients with stage II/III colorectal cancer (CRC) have a high recurrence rate after radical resection. We aimed to develop a novel tool to stratify patients with different recurrence-risk for optimizing decision-making in post-operative surveillance and therapeutic reg...
保存先:
| 出版年: | Cancer Cell Int |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8265123/ https://ncbi.nlm.nih.gov/pubmed/34233675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-021-02070-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|